GSK will be filing for approval of bepirovirsen in hepatitis B to global regulatory authorities based on the Phase III data.

Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), a clinical stage innovative drug development company focused on developing innovative therapies for immune and ...

The president posted the jobs data on his Truth Social account on Thursday evening ahead of the official release Friday.

GSK’s potential “functional cure” for hepatitis B drug has proven its worth in a pair of hotly anticipated phase 3 studies, setting up the pharma for a push to the FDA.

As for safety, the most common adverse reactions reported with treatment were mild to moderate nausea, edema, pain in extremities and back, and fatigue. No cases of relacorilant-induced hypokalemia, ...

The 2026 World Cup will be played on grass, even at NFL stadiums that feature synthetic fields. Turf, and debate over it, ...

MoonLake regains momentum after the FDA Type B meeting allows BLA submission for sonelokimab in HS without additional trials.

Immuneering Corporation stays a Strong Buy: pancreatic cancer combo shows 64% 12‑mo OS, strong safety, and clear catalysts ...

The Malinauskas Labor Government's investments in police and legislative reform are making a difference to the community with statistics revealing ...

Students aiming to equip themselves with the skills and experience necessary for the future workforce can seek: Learning ...